California-based startup Curative offers COVID-19 vaccinations and testing across the US, but as demand for testing eases, the company is shifting its focus to rolling out a health plan. new health.
Due to the change of course, the company will lay off 109 employees in early November.
The company has filed notice of the Worker Adjustment and Retraining Notice Act to the state of California. WARN is a U.S. labor law that requires employers with 100 or more employees to provide prior notice of mass layoffs and plant closures 60 calendar days in advance.
“As the company transitions from testing for COVID-19 to rolling out a new health plan in Austin, Texas, we are reducing our workforce in some areas of the company and expanding in others. “, a Curative spokesperson said MobiHealthNews.
Curative will roll out the employer-based health plan first in Travis and Williamson counties in Texas, then throughout Texas over the next year. Then it plans to offer more of its plans Statuses.
The plan will provide $0 copay and $0 deductible for in-network care. To be eligible, members must complete a Preventive Health Basic Visit within 120 days to continue receiving a $0.0 copay and $0 out-of-pocket deductible. in-network care.
TREND TO BIGGER
Many digital health and medical technology companies have announced their shutdowns since the beginning of 2022.
In June, Carbon Health, a chain of healthcare clinics that provide telemedicine, has laid off 250 employees, representing about 8% of the company’s workforce. Carbon derives significant revenue from its COVID-19 services, but the company closed many of those services as the pandemic turned.
Calma company that has thrived during the pandemic by offering an app to help with meditation, stress relief and sleep, has laid off 20% of its employees due to what CEO David Ko says is the company “are not [being] immune to the effects of the current economic environment. ”
Cue Health, offers home molecular COVID-19 testing, lay off 170 production workers early this summer.
Most recent, GoodRx, a company known for its prescription price transparency tools, has laid off about 140 of its workforce, or about 16% of its employees. The cuts mainly affect its marketing and technology-focused segments.
Other companies facing mass layoffs include 23andMe, one of the largest gene platforms in the US, payments company Cedarhealthcare automation company Oliveand AI-powered genomics and clinical data company Sema4.